Adenosine receptor subtypes modulate two major functional pathways for hippocampal serotonin release

被引:104
作者
Okada, M [1 ]
Nutt, DJ
Murakami, T
Zhu, G
Kamata, A
Kawata, Y
Kaneko, S
机构
[1] Hirosaki Univ, Sch Med, Dept Neuropsychiat, Hirosaki, Aomori 0368216, Japan
[2] Univ Bristol, Psychopharmacol Unit, Bristol BS8 1TD, Avon, England
关键词
adenosine; serotonin; microdialysis; voltage-sensitive Ca2+ channel; protein kinase; SNARE;
D O I
10.1523/JNEUROSCI.21-02-00628.2001
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
To clarify the mechanisms of interaction between adenosine A(1) receptor (A1-R) and adenosine A(2) receptor (A2-R) on neurotransmitter release, this study determined the functional interactions among adenosine receptors (AD-Rs), voltage-sensitive Ca2+ channels (VSCCs), protein kinases (PKs), and synaptic proteins [N-ethylmaleimide-sensitive factor (NSF) attachment protein (SNAP) receptors] on hippocampal serotonin release using in vivo microdialysis in freely moving rat. Basal serotonin release was regulated by two functional complexes: N-type VSCC (N-VSCC)/calcium-phospholipid-dependent protein kinase (PKC)/syntaxin (major pathway) and P-type VSCC (PVSCC)/cyclic AMP-dependent protein kinase (PKA)/synaptobrevin (minor pathway). However, K+-evoked serotonin release was regulated by N-VSCC/PKC/syntaxin (minor pathway) and P-VSCC/PKA/synaptobrevin (major pathway). A1-R antagonists increased basal serotonin release, which was reduced by inhibitors of N-VSCC, PKC, and syntaxin predominantly and by inhibitors of PKA and synaptobrevin weakly, but was not affected by P-VSCC inhibitor. In the presence of A1-R antagonist, A2-R agonists increased basal serotonin release, which was inhibited by inhibitors of P-VSCC, PKA, and synaptobrevin predominantly and reduced by inhibitors of N-VSCC, PKC, and syntaxin weakly. Under the condition of activation of adenylate cyclase in the absence of A1-R antagonists, A2-R agonists increased basal serotonin release. A1-R antagonist and A2-R agonist enhanced K+-evoked serotonin release, which was inhibited by inhibitors of P-VSCC, PKA, and synaptobrevin predominantly. These results suggest that an activation of A1-R suppresses serotonin release via inhibition of both N-VSCC/PKC/syntaxin and P-VSCC/PKA/synaptobrevin pathways, and an activation of A2-R stimulates serotonin release via enhancement of the P-VSCC/PKA/synaptobrevin pathway. Therefore, PKA activity plays an important role in the interaction between A1-R and A2-R on hippocampal serotonin release.
引用
收藏
页码:628 / 640
页数:13
相关论文
共 57 条
[41]   PRIMARY STRUCTURE OF A CALCIUM-CHANNEL THAT IS HIGHLY EXPRESSED IN THE RAT CEREBELLUM [J].
STARR, TVB ;
PRYSTAY, W ;
SNUTCH, TP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (13) :5621-5625
[42]   THE SYNAPTIC VESICLE CYCLE - A CASCADE OF PROTEIN-PROTEIN INTERACTIONS [J].
SUDHOF, TC .
NATURE, 1995, 375 (6533) :645-653
[43]   DIFFERENT TYPES OF CALCIUM CHANNELS MEDIATE CENTRAL SYNAPTIC TRANSMISSION [J].
TAKAHASHI, T ;
MOMIYAMA, A .
NATURE, 1993, 366 (6451) :156-158
[44]   Protein phosphorylation and the regulation of synaptic membrane traffic [J].
Turner, KM ;
Burgoyne, RD ;
Morgan, A .
TRENDS IN NEUROSCIENCES, 1999, 22 (10) :459-464
[45]   ACTIVATION OF ADENOSINE A(1) AND A(2) RECEPTORS DIFFERENTIALLY MODULATES CALCIUM CHANNELS AND GLYCINERGIC SYNAPTIC TRANSMISSION IN RAT BRAIN-STEM [J].
UMEMIYA, M ;
BERGER, AJ .
NEURON, 1994, 13 (06) :1439-1446
[46]   Adenosine and cerebral ischemia: therapeutic future or death of a brave concept? [J].
Von Lubitz, DKJE .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 365 (01) :9-25
[47]   EFFECT OF OUABAIN APPLIED BY INTRASTRIATAL MICRODIALYSIS ON THE INVIVO RELEASE OF DOPAMINE, ACETYLCHOLINE, AND AMINO-ACIDS IN THE BRAIN OF CONSCIOUS RATS [J].
WESTERINK, BHC ;
DAMSMA, G ;
DEVRIES, JB .
JOURNAL OF NEUROCHEMISTRY, 1989, 52 (03) :705-712
[48]   ROLES OF N-TYPE AND Q-TYPE CA2+ CHANNELS IN SUPPORTING HIPPOCAMPAL SYNAPTIC TRANSMISSION [J].
WHEELER, DB ;
RANDALL, A ;
TSIEN, RW .
SCIENCE, 1994, 264 (5155) :107-111
[49]  
WILLIAMS M, 1991, ADENOSINE NERVOUS SY, P137
[50]  
Wu LG, 1999, J NEUROSCI, V19, P726